OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JLIC.PSX57

Jubilee Life Insurance Company Ltd

Life & Health InsuranceVerified

Jubilee Life Insurance Company Limited has a liquidity position that is characterized as medium, with a debt-to-equity ratio of 0.05, indicating a relatively low level of leverage. The company's free cash flow is positive at 661,748,000 PKR, which suggests it has the ability to fund operations and potentially return value to shareholders. However, the company's operating cash flow is negative at -10,383,855,000 PKR, which may indicate challenges in generating sufficient cash from its core operations. In terms of profitability, the company's return on equity is 13.25%, which is a strong indicator of its ability to generate profits relative to shareholders' equity. However, the return on assets is only 0.94%, suggesting that the company is not efficiently using its assets to generate profits. These figures should be compared against the industry's preferred metrics and cohort medians to determine if the company is performing above or below average in its sector. The company's business is segmented into several units, including Individual Life Unit Linked, Conventional Business, Accident & Health Business, and others. The geographic exposure is primarily within Pakistan, with no significant international operations disclosed. The revenue concentration within the domestic market may expose the company to local economic and regulatory risks. The company's growth trajectory is not explicitly detailed in the provided data, but the negative operating income of -11,714,591,000 PKR and the positive net income of 2,495,503,000 PKR suggest a complex financial situation. The company's future growth will depend on its ability to improve its operating performance and manage its cash flow effectively. The risk assessment indicates a medium liquidity risk, with a note that net cash is negative after subtracting total debt. The dilution risk is assessed as low, which implies that the company is not expected to issue additional shares that could dilute existing shareholders' equity in the near term. The company's capital structure and financial performance should be monitored for any changes that could affect its risk profile. Recent events and filings have not been provided in the input data, so no specific recent developments can be detailed. The company's financial performance and strategic direction should be evaluated in the context of its latest filings and public disclosures to understand any recent changes or initiatives.

30-day price · JLIC.PSX+14.83 (+9.4%)
Low$152.03High$176.90Close$171.81As of15 May, 00:00 UTC
Profile
CompanyJubilee Life Insurance Company Ltd
TickerJLIC.PSX
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Jubilee Life Insurance Company Limited provides life and health insurance products in Pakistan, including individual and group life insurance, takaful, and micro insurance, and is a subsidiary of Aga Khan Fund for Economic Development.

Classification. Jubilee Life Insurance Company Limited is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92.

Jubilee Life Insurance Company Limited has a liquidity position that is characterized as medium, with a debt-to-equity ratio of 0.05, indicating a relatively low level of leverage. The company's free cash flow is positive at 661,748,000 PKR, which suggests it has the ability to fund operations and potentially return value to shareholders. However, the company's operating cash flow is negative at -10,383,855,000 PKR, which may indicate challenges in generating sufficient cash from its core operations. In terms of profitability, the company's return on equity is 13.25%, which is a strong indicator of its ability to generate profits relative to shareholders' equity. However, the return on assets is only 0.94%, suggesting that the company is not efficiently using its assets to generate profits. These figures should be compared against the industry's preferred metrics and cohort medians to determine if the company is performing above or below average in its sector. The company's business is segmented into several units, including Individual Life Unit Linked, Conventional Business, Accident & Health Business, and others. The geographic exposure is primarily within Pakistan, with no significant international operations disclosed. The revenue concentration within the domestic market may expose the company to local economic and regulatory risks. The company's growth trajectory is not explicitly detailed in the provided data, but the negative operating income of -11,714,591,000 PKR and the positive net income of 2,495,503,000 PKR suggest a complex financial situation. The company's future growth will depend on its ability to improve its operating performance and manage its cash flow effectively. The risk assessment indicates a medium liquidity risk, with a note that net cash is negative after subtracting total debt. The dilution risk is assessed as low, which implies that the company is not expected to issue additional shares that could dilute existing shareholders' equity in the near term. The company's capital structure and financial performance should be monitored for any changes that could affect its risk profile. Recent events and filings have not been provided in the input data, so no specific recent developments can be detailed. The company's financial performance and strategic direction should be evaluated in the context of its latest filings and public disclosures to understand any recent changes or initiatives.
Key takeaways
  • Jubilee Life Insurance Company Limited has a strong return on equity but a weak return on assets, indicating inefficiency in asset utilization.
  • The company's liquidity position is medium, with a low debt-to-equity ratio, suggesting a conservative capital structure.
  • The company's operating cash flow is negative, which may signal operational challenges.
  • The company's growth trajectory is not clearly defined, and its future performance will depend on its ability to improve its operating performance.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • margin_outlook_rationale: The company's margin outlook is uncertain due to the negative operating income and the need to improve asset utilization.
  • rd_outlook_rationale: No specific information is provided regarding the company's research and development outlook.
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue
Gross profit
Operating income-$11.71B
Net income$2.50B
R&D
SG&A
D&A
SBC
Operating cash flow-$10.38B
CapEx-$1.04B
Free cash flow$661.7M
Total assets$265.77B
Total liabilities$246.93B
Total equity$18.83B
Cash & equivalents
Long-term debt$896.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$18.83B
Net cash-$896.3M
Current ratio
Debt/Equity0.1
ROA0.9%
ROE13.2%
Cash conversion-4.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricJLIC.PSXActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity5.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 04:17 UTC#08e907c5
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 04:18 UTCJob: 6aaa335a